Detalles de la búsqueda
1.
Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
J Transl Med
; 21(1): 10, 2023 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624443
2.
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state.
Cancer Sci
; 111(6): 1876-1886, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32187778
3.
Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
Cancer Sci
; 111(5): 1739-1749, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32167618
4.
Survival-associated alternative splicing signatures in esophageal carcinoma.
Carcinogenesis
; 40(1): 121-130, 2019 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30304323
5.
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
J Transl Med
; 17(1): 430, 2019 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31888670
6.
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable nonsmall cell lung cancer.
Transl Oncol
; 35: 101725, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37421908
7.
Global burden and temporal trends in incidence and mortality of oesophageal cancer.
J Adv Res
; 50: 135-144, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36272715
8.
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
Nat Commun
; 14(1): 6042, 2023 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758728
9.
Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.
Int Immunopharmacol
; 109: 108816, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504200
10.
Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC.
Front Oncol
; 12: 769124, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35223466
11.
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
EBioMedicine
; 84: 104268, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36116215
12.
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes.
Transl Lung Cancer Res
; 11(8): 1540-1554, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36090638
13.
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study.
EBioMedicine
; 78: 103951, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313216
14.
Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma.
Front Oncol
; 11: 749643, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35096566
15.
Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.
Clin Epigenetics
; 13(1): 229, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933667
16.
The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non-small-cell lung cancer.
Clin Transl Immunology
; 10(1): e1231, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33425353
17.
Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
Cancer Lett
; 483: 46-58, 2020 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272148
18.
Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.
Clin Transl Med
; 10(3): e128, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32659050
19.
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer.
Cell Death Dis
; 11(10): 933, 2020 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33127882
20.
ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.
Cell Death Dis
; 11(10): 853, 2020 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33056994